SEC Tracker
Get the app
BAX · XBRL financial data

Baxter International financial statements, every quarter

The same tables from 12 filings, lined up. Matched by XBRL tag: renamed lines keep their history.

Download Excel Download CSV
How these numbers work
  • Every number comes from the company's XBRL financial data filed with the SEC, and each one links to its filing.
  • Lines are matched by XBRL tag, so a line renamed between filings keeps its history.
  • * marks a quarter worked out from the filing totals: the 10-K year minus the first three quarters, or a year-to-date total minus the earlier one. Fourth-quarter earnings per share is fourth-quarter net income over the fourth-quarter weighted shares.
  • 0 means a filing states zero; a dash (—) means no filing states that number.
  • “year only” means the 10-K gives the full year but not the quarters needed to work out the fourth. A worked-out quarter of revenue, cost of revenue or operating cash flow more than twice the company's largest quarter of the two years before is shown this way too.
  • Gross profit is shown as the company reports it; a worked-out quarter must equal revenue less cost of revenue for that quarter, or it is a dash.
  • Operating income can be above gross profit when the company books other operating income between the two, shown on its own line.
  • Shares outstanding come from each filing's cover page, as of the date printed there.
  • Quarters are fiscal: Q2 FY27 is the second quarter of the company's fiscal 2027.

Income statement

CSV

Fiscal quarters (BAX's year ends in late December)

In millions of dollarsDec 31, 2023Mar 31, 2024Jun 30, 2024Sep 30, 2024Dec 31, 2024Mar 31, 2025Jun 30, 2025Sep 30, 2025Dec 31, 2025Mar 31, 2026Jun 30, 2026Sep 30, 2026
Revenue from contracts with customers3,8853,5923,8122,6992,7532,6252,8102,8352,974*2,7012,9602,976
Cost of goods and services sold2,413*2,2052,3811,6661,794*1,7641,8191,8852,397*1,8101,9281,982
Gross profit1,4721,3871,4311,033959861991950577*8911,032994
Research and development172*176173129211*140134118126*139129125
Selling, general and administrative985*1,0271,021754761*703718708761*728735730
Other operating income (expense)14*3153*40524866*424986
Operating income (loss)329*187(192)155(435)*58191172(729)*66217225
Interest incomeyear only———year only———year only———
Interest expense117*103104(14)465*81(14)(10)331*(12)(13)(13)
Other income (expense)(18)*72014*30731*(6)5253
Income tax expense (benefit)165*77548(33)*(67)11172279*1123119
Net income (loss)24537(314)140(512)12691(46)(1,128)*(15)126294
Earnings per share, basic USD per share0.480.07(0.62)0.27(1.00)0.250.18(0.09)(2.20)*(0.03)0.240.57
Earnings per share, diluted USD per share0.480.07(0.62)0.27(1.00)0.250.18(0.09)(2.21)*(0.03)0.240.57
Weighted average shares, basic millions of shares506*508510510512*512513514513*515517517
Weighted average shares, diluted millions of shares502*510510512508*514514514510*515518520

Balance sheet

CSV

Fiscal quarters (BAX's year ends in late December)

In millions of dollarsDec 31, 2023Mar 31, 2024Jun 30, 2024Sep 30, 2024Dec 31, 2024Mar 31, 2025Jun 30, 2025Sep 30, 2025Dec 31, 2025Mar 31, 2026Jun 30, 2026Sep 30, 2026
Cash and cash equivalents3,1943,0262,0951,4201,7642,2941,6861,7261,9662,0172,1501,975
Accounts receivable2,6902,5212,6391,7291,6791,6461,7731,7771,8611,6981,8561,783
Inventory2,8242,9882,9852,1032,0462,1702,3842,4602,2322,3162,2592,300
Prepaid and other current assets892865874720753925906970813816724768
Total current assets9,6009,4008,5938,8648,8537,0356,7496,9336,8726,8476,9896,826
Property and equipment, net4,4334,3704,3142,8332,8702,7172,8022,8122,9102,9132,9132,873
Right-of-use asset524531524327306301289270276277261260
Goodwill6,5146,4306,0015,7835,2755,3385,3955,4004,9294,8994,8864,871
Total assets28,27627,78826,31226,67625,78221,30421,04621,06720,05519,84619,79119,414
Accounts payable1,2411,3291,2518419689639959539991,0861,0341,024
Accrued liabilities2,5942,4022,4121,7721,8611,8561,9362,0671,9681,7651,7131,941
Total current liabilities6,5036,3656,1316,2006,5113,4812,9393,7752,9703,6933,5913,809
Lease liability, non-current438444439259243235225210223224208206
Total liabilities19,80819,55318,60418,73418,75814,25013,75313,85313,95313,83013,61212,939
Retained earnings16,11416,00315,53915,52914,92914,96814,97014,83713,70513,68513,80614,095
Total stockholders' equity8,4028,1737,6437,8726,9647,0817,3207,2416,1296,0436,2066,502
Total liabilities and equity28,27627,78826,31226,67625,78221,30421,04621,06720,05519,84619,79119,414
Common shares outstanding (cover page) millions of shares508510510511512513514514514516517517

Cash flows

CSV

Fiscal quarters (BAX's year ends in late December)

In millions of dollarsDec 31, 2023Mar 31, 2024Jun 30, 2024Sep 30, 2024Dec 31, 2024Mar 31, 2025Jun 30, 2025Sep 30, 2025Dec 31, 2025Mar 31, 2026Jun 30, 2026Sep 30, 2026
Net income (loss)24537(314)140(512)12691(46)(1,128)*(15)126294
Stock-based compensation30*2528*22*39*1035*35*37*1033*30*
Depreciation and amortization324*335288*129*245*247257*237*240*237239*239*
Net cash from operating activities531*163115*253*488*(193)217*237*584*213285*558*
Net cash from investing activities(230)*(166)(91)*(164)*(205)*3,265(115)*(111)*(198)*(133)(117)*(110)*
Share repurchases0*———year only———————
Dividends paid147*147148*148*147*8787*87*87*55*5*
Proceeds from long-term debtyear only———year only———year only———
Net cash from financing activities(2,935)*(140)(936)*(146)*141*(3,226)(762)*(81)*(147)*(11)(31)*(620)*
Net change in cash(2,594)*(168)(934)*(16)*334*(118)(608)*40*240*51137*(175)*

Compare with peers

SIC 3841 and related industry codes, similar size. Each row is the latest quarter reported.

How peers are chosen
  • SIC 3841 and related industry codes with public float (or, where float is missing, quarterly revenue) between 0.2x and 5x the company's.
  • Each row is the latest quarter the company has reported, named in the Quarter column; when that filing is a 10-K, it is the fourth quarter, never the full year.
  • * marks a quarter worked out from the filing totals: for a 10-Q, the year-to-date total less the earlier one.
CompanyCash ($M)Revenue, quarter ($M)Operating cash flow, quarter ($M)Shares outstandingQuarter
Baxter International1,9752,976558*517.3M 10-QSep 30, 2026
West Pharmaceutical Services464875190*69.7M 10-QSep 30, 2026
Zimmer Biomet Holdings4102,177448*190.7M 10-QJun 30, 2026
Hologic2,1681,048230223.2M 10-QDec 27, 2025
Solventum4032,209227*170.2M 10-QJun 30, 2026
Medline2,3277,685715*not reported 10-QJun 27, 2026
Insulet53580288*69.4M 10-QJun 30, 2026
Align Technology1,1031,056193*71.0M 10-QJun 30, 2026
STERIS4821,49336797.5M 10-QJun 30, 2026

Not investment advice. Not affiliated with the U.S. SEC.